These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 792851)

  • 1. A randomized prospective clinical trial of antilymphocyte globulin in 100 cadaveric renal transplants.
    Sansom JR; Barnes AD; Hall CL
    Postgrad Med J; 1976; 52(5 Suppl):75-8. PubMed ID: 792851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controlled trial of antilymphocyte globulin in cadaveric transplantation.
    Jakobsen J; Flatmark A; Sodal G; Thorsby E
    Postgrad Med J; 1976; 52(5 Suppl):72-4. PubMed ID: 792850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antilymphocyte globulin in cadaveric renal transplantation--a controlled trial.
    Jakobsen A; Sødal G; Flatmark A; Thorsby E
    Scand J Urol Nephrol Suppl; 1977; (42):94-6. PubMed ID: 356233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Canadian clinical trial of antilymphocyte globulin in human cadaver renal transplantation.
    Taylor HE; Ackman CF; Horowitz I
    Can Med Assoc J; 1976 Dec; 115(12):1205-8. PubMed ID: 793705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antilymphocyte globulin and renal transplantation.
    Tagnon A
    Postgrad Med J; 1976; 52(5 Suppl):64-6. PubMed ID: 792848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Past experience and future studies with antilymphocyte globulin in recipients of kidney homografts.
    Putnam CW; Bell RH; Beart RW; Anderson JT; Weil R
    Postgrad Med J; 1976; 52(5 Suppl):59-63. PubMed ID: 792847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment with antilymphocyte globulin (ALG) and evolution of renal transplant: observations of 42 cases].
    Civati G; Grillo C; Di Belgioioso GB; Rovati C; Surian M; Busnach G; Broggi L; Ferrari L
    Boll Ist Sieroter Milan; 1978 May; 57(2):165-72. PubMed ID: 365193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experience with antilymphocyte globulin in 144 renal transplant recipients.
    Lundgren G; Collste L; Groth CG; Krzymansky M; Magnusson G; Quadracci L; Ringdén O; Svehag SE
    Postgrad Med J; 1976; 52(5 Suppl):67-71. PubMed ID: 792849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical experience with antilymphocyte-globulin in cadaveric kidney transplantation.
    Ahlmen J; Storm B; Brynger H; Sandberg L; Gelin LE
    Scand J Urol Nephrol Suppl; 1977; (42):90-3. PubMed ID: 356232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of antilymphocyte globulin in renal allograft rejection. A controlled study.
    Birkeland SA
    Postgrad Med J; 1976; 52(5 Suppl):82-8. PubMed ID: 792853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New experiences with antilymphocyte globulin in human organ transplantation.
    Largiadér F; Ruckert R
    Postgrad Med J; 1976; 52(5 Suppl):79-81. PubMed ID: 792852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alternative antirejection treatment with steroids or antilymphoblast globulin in renal transplant patients receiving cyclosporine.
    Veremis SA; Maddux MS; Pollak R; Kline SS; Mozes MF
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1893-5. PubMed ID: 3079056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute rejection episodes after renal transplantation in children.
    Hoyer PF; Offner G; Brodehl J
    Clin Nephrol; 1983 Feb; 19(2):61-6. PubMed ID: 6340876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A controlled trial with AHLG Behring: lack of effect on cadaveric renal graft survival.
    Jakobsen A; Flatmark A; Lundgren G; Solheim B; Groth CG
    Scand J Urol Nephrol Suppl; 1981; 64():205-12. PubMed ID: 6755682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experience with 130 consecutive renal transplants in the Middle East with special reference to histocompatibility matching, antirejection therapy with antilymphocyte globulin (ALG), and prolonged preservation of imported cadaveric grafts.
    Abouna GM; Kumar MS; White AG; Daddah S; John P; Samhan M; Omar OF; Kusma G
    Transplant Proc; 1984 Aug; 16(4):1114-7. PubMed ID: 6380057
    [No Abstract]   [Full Text] [Related]  

  • 16. [immunosuppression following kidney transplantation using antilymphocyte globulin followed by treatment with cyclosporin. A prospective study].
    Grundmann R; Wienand P; Holland M; Meider G
    Dtsch Med Wochenschr; 1986 Apr; 111(17):659-64. PubMed ID: 3516619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beneficial effect of concomitant induction with antilymphoblast globulin, cyclosporine, and steroids on long-term renal allograft outcome.
    Koga A; Moreso FJ; Seron D; Gil-Vernet S; Cruzado JM; Castelao AM; Grinyó JM
    Transplant Proc; 2004 Jun; 36(5):1305-7. PubMed ID: 15251318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An evaluation of early cyclosporine versus ALG therapy for primary cadaver renal allografts with immediate function.
    Adams MB; Johnson CP; Roza AM
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1606-8. PubMed ID: 2652523
    [No Abstract]   [Full Text] [Related]  

  • 19. Cadaveric kidney transplantation under prophylactic polyclonal antibody immunosuppression with anti-lymphoblast globulin versus anti-thymocyte globulin.
    Indudhara R; Novick AC; Hodge E; Goormastic M; Papajcik D; Mastroianni B; Cook D
    Urology; 1996 Jun; 47(6):807-12. PubMed ID: 8677568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antilymphocyte globulin with a small dose of cyclosporine A and prednisone as the induction of immunosuppression in renal allograft recipients.
    Boratyńska M; Szepietowski T; Szewczyk Z; Szydłowski Z
    Arch Immunol Ther Exp (Warsz); 1992; 40(2):163-8. PubMed ID: 1299176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.